Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow

NCT02757885 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

PROCEDURE: Bone Marrow Transplant (BMT)
DRUG: Hydroxyurea
DRUG: Thiotepa
DRUG: Fludarabine monophosphate
DRUG: Cyclophosphamide
OTHER: Rabbit Anti-thymocyte Globulin
RADIATION: Total Body Irradiation

Sponsor

Emory University